Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AUPH
IMNM
Add up to 3 more stocks
AUPH
Aurinia Pharmaceuticals Inc.
+0.31%
$15.77+0.05Delayed quote: Oct 6, 2026, 11:20 AM EDT
Market Cap
$2.03B
52W Range
$10.90 - $19.25
IMNM
Immunome, Inc.
-2.93%
$20.55-0.62Delayed quote: Oct 6, 2026, 11:20 AM EDT
Market Cap
$1.96B
52W Range
$13.41 - $30.06
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 6.89 | N/A |
| Forward P/E | 16.70 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.30 | 3.74 |
| P/S Ratio | 6.51 | N/A |
| P/FCF Ratio | 11.68 | N/A |
| EV/EBITDA | 11.22 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 90.4% | 57.4% |
| Operating Margin | 37.1% | -3084.8% |
| Net Margin | 100.8% | -3060.0% |
| ROE | 51.1% | -48.4% |
| ROA | 39.6% | -45.0% |
| ROIC | 21.8% | -51.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.42 | 15.08 |
| Quick Ratio | 4.97 | 15.08 |
| Debt/Equity | 0.10 | 0.01 |
| Interest Coverage | 24.23 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.